Inhibitors of the TGF-β superfamily and their clinical applications

K. Tsuchida; Y. Sunada; S. Noji; T. Murakami; A. Uezumi; M. Nakatani

doi:10.2174/138955706778742759

Inhibitors of the TGF-β superfamily and their clinical applications

K. Tsuchida, Y. Sunada, S. Noji, T. Murakami, A. Uezumi, M. Nakatani

Division for Therapies against Intractable Diseases

Research output: Contribution to journal › Review article › peer-review

32 Citations (Scopus)

Abstract

The transforming growth factor-β (TGF-β) superfamily includes TGF-β s, activin, myostatin and bone morphogenetic proteins. Misregulation of the activity of TGF-β family members is involved in pathogenesis of cancer, muscular dystrophy, obesity and bone and tooth remodeling. Natural inhibitors for the TGF-β superfamily regulate fine-tuning of activity of TGF-β family in vivo. In addition to natural inhibitors for the TGF-β family, soluble forms of receptors for the TGF-β family, blocking monoclonal antibodies and small chemical TGF-β inhibitors have been developed. In this review, we summarize recent advances in our understanding of inhibitors for the TGF-β superfamily and their medical applications.

Original language	English
Pages (from-to)	1255-1261
Number of pages	7
Journal	Mini-Reviews in Medicinal Chemistry
Volume	6
Issue number	11
DOIs	https://doi.org/10.2174/138955706778742759
Publication status	Published - 11-2006

All Science Journal Classification (ASJC) codes

Molecular Medicine
Pharmacology
Drug Discovery
Cancer Research

Access to Document

10.2174/138955706778742759

Fingerprint Dive into the research topics of 'Inhibitors of the TGF-β superfamily and their clinical applications'. Together they form a unique fingerprint.

Cite this

@article{857e493b4f954c77a6ebbeb16529f717,

title = "Inhibitors of the TGF-β superfamily and their clinical applications",

abstract = "The transforming growth factor-β (TGF-β) superfamily includes TGF-β s, activin, myostatin and bone morphogenetic proteins. Misregulation of the activity of TGF-β family members is involved in pathogenesis of cancer, muscular dystrophy, obesity and bone and tooth remodeling. Natural inhibitors for the TGF-β superfamily regulate fine-tuning of activity of TGF-β family in vivo. In addition to natural inhibitors for the TGF-β family, soluble forms of receptors for the TGF-β family, blocking monoclonal antibodies and small chemical TGF-β inhibitors have been developed. In this review, we summarize recent advances in our understanding of inhibitors for the TGF-β superfamily and their medical applications.",

author = "K. Tsuchida and Y. Sunada and S. Noji and T. Murakami and A. Uezumi and M. Nakatani",

year = "2006",

month = nov,

doi = "10.2174/138955706778742759",

language = "English",

volume = "6",

pages = "1255--1261",

journal = "Mini-Reviews in Medicinal Chemistry",

issn = "1389-5575",

publisher = "Bentham Science Publishers B.V.",

number = "11",

}

TY - JOUR

T1 - Inhibitors of the TGF-β superfamily and their clinical applications

AU - Tsuchida, K.

AU - Sunada, Y.

AU - Noji, S.

AU - Murakami, T.

AU - Uezumi, A.

AU - Nakatani, M.

PY - 2006/11

Y1 - 2006/11

N2 - The transforming growth factor-β (TGF-β) superfamily includes TGF-β s, activin, myostatin and bone morphogenetic proteins. Misregulation of the activity of TGF-β family members is involved in pathogenesis of cancer, muscular dystrophy, obesity and bone and tooth remodeling. Natural inhibitors for the TGF-β superfamily regulate fine-tuning of activity of TGF-β family in vivo. In addition to natural inhibitors for the TGF-β family, soluble forms of receptors for the TGF-β family, blocking monoclonal antibodies and small chemical TGF-β inhibitors have been developed. In this review, we summarize recent advances in our understanding of inhibitors for the TGF-β superfamily and their medical applications.

AB - The transforming growth factor-β (TGF-β) superfamily includes TGF-β s, activin, myostatin and bone morphogenetic proteins. Misregulation of the activity of TGF-β family members is involved in pathogenesis of cancer, muscular dystrophy, obesity and bone and tooth remodeling. Natural inhibitors for the TGF-β superfamily regulate fine-tuning of activity of TGF-β family in vivo. In addition to natural inhibitors for the TGF-β family, soluble forms of receptors for the TGF-β family, blocking monoclonal antibodies and small chemical TGF-β inhibitors have been developed. In this review, we summarize recent advances in our understanding of inhibitors for the TGF-β superfamily and their medical applications.

UR - http://www.scopus.com/inward/record.url?scp=33750736310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750736310&partnerID=8YFLogxK

U2 - 10.2174/138955706778742759

DO - 10.2174/138955706778742759

M3 - Review article

C2 - 17100637

AN - SCOPUS:33750736310

VL - 6

SP - 1255

EP - 1261

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 11

ER -